Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating oophoroma

A composition and ovarian cancer technology, applied in the field of pharmaceutical compositions for the treatment of ovarian cancer, can solve the problems of lack of in-depth discussion in theoretical research, and lack of unified syndrome differentiation and classification, and achieve significant curative effect and strong cell proliferation inhibition effect

Inactive Publication Date: 2015-12-23
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many problems in the treatment. For example, there is no unified syndrome differentiation in the application of traditional Chinese medicine in the treatment of ovarian cancer. Most of them are based on the experience of doctors, and there is no in-depth discussion in theoretical research. Commitment should be devoted to the combination of theoretical research, experimental research and clinical practice of traditional Chinese medicine, so as to fully understand the mechanism and curative effect of traditional Chinese medicine in the treatment of ovarian cancer, and actively explore effective ways of traditional Chinese medicine to improve clinical efficacy, so that postoperative cooperation with traditional Chinese medicine treatment or The curative effect and 5-year survival rate of traditional Chinese medicine treatment are greatly improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1: Pharmaceutical composition for treating ovarian cancer and preparation method thereof

[0036] The composition and weight portion of the raw material drug of the pharmaceutical composition for treating ovarian cancer are:

[0037] 70 parts by weight of Artemisia annua 45 parts by weight of nettles 45 parts by weight of almonds 35 parts by weight of snails 15 parts by weight of protobasaltine 5.5 parts by weight of terresin A4 parts by weight;

[0038] Preparation:

[0039] (1) Take nettles and almonds according to the proportion of the raw materials, mix well, first use 60% ethanol as a solvent, warm immersion and extract at 50 ° C, the extraction times are 4 times, and the extraction time is 4 hours each time. , the dosage of each solvent is 20 times of the total weight of the nettle and almond seeds, filtered to obtain medicinal residues A and an extract, the extract is recovered ethanol, concentrated, and dried to obtain the extract A;

[0040] (2) Take ...

Embodiment 2

[0042] Example 2: Pharmaceutical composition for treating ovarian cancer and preparation method thereof

[0043] The composition and weight portion of the raw material drug of the pharmaceutical composition for treating ovarian cancer are:

[0044]65 parts by weight of Artemisia annua, 50 parts by weight of Nettles, 30 parts by weight of almond kernels, 20 parts by weight of snails, 5 parts by weight of protobasaltine, 5 parts by weight of terresin A, 5 parts by weight;

[0045] Preparation:

[0046] (1) Take nettles and almonds according to the proportion of the raw materials, mix well, first use 60% ethanol as a solvent, warm immersion and extract at 50 ° C, the extraction times are 4 times, and the extraction time is 4 hours each time. , the dosage of each solvent is 20 times of the total weight of the nettle and almond seeds, filtered to obtain medicinal residues A and an extract, the extract is recovered ethanol, concentrated, and dried to obtain the extract A;

[0047]...

Embodiment 3

[0049] Example 3: Pharmaceutical composition for treating ovarian cancer and preparation method thereof

[0050] The composition and weight portion of the raw material drug of the pharmaceutical composition for treating ovarian cancer are:

[0051] 75 parts by weight of Artemisia annua 40 parts by weight of nettles 40 parts by weight of almonds 40 parts by weight of snails 10 parts by weight of protobasal 6 parts by weight of cinnabar A3 weight parts;

[0052] Preparation:

[0053] (1) Take nettles and almonds according to the proportion of the raw materials, mix well, first use 60% ethanol as a solvent, warm immersion and extract at 50 ° C, the extraction times are 4 times, and the extraction time is 4 hours each time. , the dosage of each solvent is 20 times of the total weight of the nettle and almond seeds, filtered to obtain medicinal residues A and an extract, the extract is recovered ethanol, concentrated, and dried to obtain the extract A;

[0054] (2) Take Artemisia...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating oophoroma. The pharmaceutical composition is prepared by proportioning the following raw materials: artemisia hedinii, nettle, almond, littleleaf lemmaphyllum, protostemonine and justicidin A, and the pharmaceutical composition can be prepared into various dosage forms according to conventional preparation processes, and the curative effect of treating oophoroma is obvious.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a pharmaceutical composition for treating ovarian cancer. Background technique [0002] Ovarian cancer is one of the three most common malignant tumors in the female reproductive system, accounting for about 20% of female reproductive tract malignant tumors. The incidence rate in China ranks third only after cervical cancer and body cancer. It lacks early specific symptoms and is highly occult. About two-thirds of them are already in the middle and late stages when they are discovered. The 5-year survival rate hovers at 30% to 40%, and the mortality rate ranks first among gynecological malignant tumors. At present, a comprehensive treatment based on surgery and chemotherapy is usually used in clinical practice. However, with the deepening of treatment, the toxic and side effects of chemotherapy drugs and the drug resistance of the body have become...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/736A61P35/00A61K31/365A61K31/55
Inventor 张秀华
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com